Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Cato Sept. Same-store Sales Down 3%; Sees Q3 EPS At High End Of Prior Range

RELATED NEWS
Trade CATO now with 

Cato Corp. (CATO: Quote) reported that same-store sales for five weeks ended October 5, 2013 decreased 3% from the five weeks ended September 29, 2012. Sales for the five weeks were $72.9 million, a 3% increase over sales of $71.1 million last year.

Sales for the thirty-five weeks ended October 5, 2013 were $628.6 million, down 1% to sales of $637.5 million for the thirty-five weeks ended September 29, 2012. The Company's year-to-date same-store sales decreased 3% from the prior year.

The company now expect third quarter earnings per share will be at the higher end of its guidance range of $0.02 to $0.09 versus $0.16 last year.

Click here to receive FREE breaking news email alerts for Cato Corp. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Apple Inc. said Tuesday after the markets closed that its third quarter profit rose 12% from last year, as sales surged and margins improved amid strong sales of its iPhones and Mac computers. The company's quarterly earnings per share also came in above analysts' expectations, but its quarterly sales fell short of analysts' forecast. United Nations Secretary-General Ban Ki-moon on Tuesday urged both Israelis and Palestinians to stop the fighting that has been raging for the past two weeks in the Gaza Strip, and pleaded with the two sides to return to dialogue with the aim of addressing the underlying causes of the repeated cycles... After moving notably higher in early trading on Tuesday, stocks continued to perform well throughout the session. The gains on the day offset the modest weakness that was seen in the previous session, extending the recent back-and-forth movement by the markets.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.